Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03365310Unknown
Randomised, open-label trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoint: Frailty Score at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03365310.